IMPROVEMENT OF HEMOGLOBIN LEVELS IN PREGNANT WOMEN WITH ANEMIA THROUGH DRAGON FRUIT CONSUMPTION
Pregnant women are at risk of experiencing anemia, which can have health impacts such as bleeding and giving birth to low birth weight babies (LBW). The global prevalence of anemia is 43%, while in Indonesia it is 37.1%, and in the Rantau Pulung Community Health Center (Puskesmas) area, it is 39.3%. Efforts to address low hemoglobin levels often involve regular consumption of iron tablets during pregnancy. Non-pharmacological interventions include the consumption of dragon fruit, rich in vitamin C, vitamin B1, vitamin B2, vitamin B3, and protein, to increase hemoglobin levels. To determine the influence of dragon fruit on increasing hemoglobin levels in pregnant women with anemia in the working area of the Rantau Pulung Community Health Center. This study utilized a quasi-experimental design with a pre-test post-test non-equivalent control group. The study population included a total of 26 pregnant women with anemia. The sampling technique used was total sampling, resulting in 26 participants divided into an experimental group of 13 and a control group of 13. The measurement tool was observation of hemoglobin levels. Data analysis employed paired t-tests and independent t-tests. There was a difference in hemoglobin levels before and after the administration of iron tablets combined with dragon fruit by 1.1692 g%, and a difference in hemoglobin levels before and after the administration of iron tablets by 0.7077 g%. The administration of iron tablets combined with dragon fruit was effective in increasing hemoglobin levels in pregnant women in the working area of the Rantau Pulung Community Health Center in East Kutai Regency, with a p-value of 0.004. Consuming 500 g of dragon fruit daily can increase the hemoglobin levels of pregnant women due to its content of vitamin C, vitamin B1, vitamin B2, vitamin B3, and protein. The administration of dragon fruit effectively increases hemoglobin levels in pregnant women.
Copyright (c) 2023 Rahmiati -, Jasmawati -, Lukman Nulhakim
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with IJNMS agree to the following terms
- Authors retain copyright licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work non-commercially with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). Authors can archive pre-print and post-print or publisher's version/PDF.